Activating Mutations in the Gene Encoding the ATP-Sensitive Potassium-Channel Subunit Kir6.2 and Permanent Neonatal Diabetes
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K(ATP)) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we hypothesized that activating mutations in the gene encoding the Kir6.2 subunit of this channel (KCNJ11) cause neonatal diabetes. METHODS: We sequenced the KCNJ11 gene in 29 patients with permanent neonatal diabetes. The insulin secretory response to intravenous glucagon, glucose, and the sulfonylurea tolbutamide was assessed in patients who had mutations in the gene. RESULTS: Six novel, heterozygous missense mutations were identified in 10 of the 29 patients. In two patients the diabetes was familial, and in eight it arose from a spontaneous mutation. Their neonatal diabetes was characterized by ketoacidosis or marked hyperglycemia and was treated with insulin. Patients did not secrete insulin in response to glucose or glucagon but did secrete insulin in response to tolbutamide. Four of the patients also had severe developmental delay and muscle weakness; three of them also had epilepsy and mild dysmorphic features. When the most common mutation in Kir6.2 was coexpressed with sulfonylurea receptor 1 in Xenopus laevis oocytes, the ability of ATP to block mutant K(ATP) channels was greatly reduced. CONCLUSIONS: Heterozygous activating mutations in the gene encoding Kir6.2 cause permanent neonatal diabetes and may also be associated with developmental delay, muscle weakness, and epilepsy. Identification of the genetic cause of permanent neonatal diabetes may facilitate the treatment of this disease with sulfonylureas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“can be treated with high-dose sulfonylureas despite being insulin dependent also provide a compelling case for genetic evaluation of monogenic diabetes with therapeutic and prognostic implications ( 2 – 6 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings that neonatal diabetes is most commonly due to activating mutations in genes encoding the ATP-sensitive potassium channel subunits Kir6.2 or SUR1”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea Receptor
Inagaki, N., Gonoi, T., Clement, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., & Bryan, J. (1995) · Science · doi:10.1126/science.270.5239.1166 · Cited by 1,709
Cross sectional stature and weight reference curves for the UK, 1990.
Freeman, J. V., Cole, T. J., Chinn, S., Jones, P. R., White, E. M., & Preece, M. A. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.1.17 · Cited by 1,457
Stoffers, D. A., Zinkin, N. T., Stanojevic, V., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng0197-106 · Cited by 1,106
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Crystal Structure of the Potassium Channel KirBac1.1 in the Closed State
Kuo, A., Gulbis, J. M., Antcliff, J. F., Rahman, T., Lowe, E. D., Zimmer, J., Cuthbertson, J., Ashcroft, F. M., Ezaki, T., & Doyle, D. A. (2003) · Science · doi:10.1126/science.1085028 · Cited by 785
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Self-citationAssociation and Stoichiometry of KATP Channel Subunits
Clement, J. P., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., Aguilar-Bryan, L., & Bryan, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80321-9 · Cited by 692
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Self-citationMutations in the glucokinase gene of the fetus result in reduced birth weight
Hattersley, A. T., Beards, F., Ballantyne, E., Appleton, M., Harvey, R., & Ellard, S. (1998) · Nature Genetics · doi:10.1038/953 · Cited by 594
Self-citation
Cited by
Items 701–800 of 1,000
Identification of insulin gene variants in neonatal diabetes
Gohar, N. A., Rabie, W. A., Sharaf, S. A. E.-A., Elsharkawy, M. M., Mira, M. F., Tolba, A., & Aly, H. Z. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1199674 · Cited by 9
“or ABCC8 or heterozygous mutations in the INS gene [9,10].”
BackgroundBauer, I., Rimbach, G. H., Cordeiro, S., Bosy‐Westphal, A., Weghuber, J., Ipharraguerre, I. R., & Lüersen, K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1396292 · Cited by 10
Bankura, B., Pattanayak, A. K., Ghosh, S., Guria, S., Sinha, A., & Das, M. (2022) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2022.100066 · Cited by 9
Loss of Nexmif results in the expression of phenotypic variability and loss of genomic integrity
Stekelenburg, C., Blouin, J., Santoni, F. A., Zaghloul, N. A., O’Hare, E. A., Dusaulcy, R., Maechler, P., & Schwitzgebel, V. (2022) · Scientific Reports · doi:10.1038/s41598-022-17845-1 · Cited by 10
Desmoglein-2 is important for islet function and β-cell survival
Min, K. K. M., Rojas‐Canales, D. M., Penko, D., DeNichilo, M. O., Cockshell, M. P., Ffrench, C. B., Thompson, E. J., Asplund, O., Drogemuller, C., Prasad, R. B., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05326-2 · Cited by 9
“Interestingly, a comparative analysis of DSG2 expression in a second independent dataset of human islets [32] suggests that it is ranked in the top 10% of all islet genes and sits between the highly expressed insulin (INS) and a well-known β-cell gene, the potassium voltage-gated channel subfamily J member 11 gene (KC…”
BackgroundGenetic perspectives on childhood monogenic diabetes: Diagnosis, management, and future directions
Sun, H., & Lin, X.-Y. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i12.1738 · Cited by 10
Zhou, Z., Gong, M., Pande, A., Margineanu, A., Lisewski, U., Purfürst, B., Zhu, H., Liang, L., Jia, S., Froehler, S., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110291 · Cited by 11
“Indeed, further studies and a broader patient cohort are essential to fully clarify the contribution of a disrupted KCNQ1 mutation to hereditary diabetes such as PNDM. Importantly, our in vitro diseasemodel was ableto clearly demonstrate a switchfrom hyperexcitability to a weakenedsecretoryphenotype and an increased s…”
Influentialpeng, X., Wang, K., & Chen, L. (2024) · Life Metabolism · doi:10.1093/lifemeta/loae038 · Cited by 13
Management of Diabetes in Children
Wolfsdorf, J. I., & Garvey, K. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00049-4 · Cited by 13
Katanić, D., Vorgučin, I., Hattersley, A. T., Ellard, S., Houghton, J., Obreht, D., Pogančev, M. K., Vlaški, J., & Pavkov, D. J. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.04.021 · Cited by 11
“[4] Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, et al.”
Self-citationEngelbrechtsen, L., Gybel-Brask, D. J., Mahendran, Y., Crusell, M. K. W., Hansen, T. H., Schnurr, T. M., Høgdall, E. V. S., Skibsted, L., Hansen, T. F., & Vestergaard, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-26752-3 · Cited by 11
Genetic spectrum of neonatal diabetes
Kočova, M. (2020) · Balkan Journal of Medical Genetics · doi:10.2478/bjmg-2020-0027 · Cited by 10
“They act through increase of activity of ATP-sensitive potassium channels located on the β-cell membrane [35,59,60].”
BackgroundSperling, M. A., Wolfsdorf, J. I., Menon, R. K., Tamborlane, W. V., Maahs, D. M., Battelino, T., & Phillip, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00021-x · Cited by 13
Ramu, Y., Yamakaze, J., Zhou, Y., Hoshi, T., & Lü, Z. (2022) · eLife · doi:10.7554/elife.77026 · Cited by 9
Treatment of neurometabolic epilepsies: Overview and recent advances
Latzer, I. T., & Pearl, P. L. (2023) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2023.109181 · Cited by 9
Mancioppi, V., Pozzi, E., Zanetta, S., Missineo, A., Savastio, S., Barbetti, F., Mellone, S., Giordano, M., & Rabbone, I. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1143736 · Cited by 10
Dance, A., Fernandes, J., Toussaint, B., Vaillant, E., Boutry, R., Baron, M., Loiselle, H., Balkau, B., Charpentier, G., Franc, S., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101867 · Cited by 11
“Elevated intracellular calcium levels eventually stimulate insulin-containing vesicle fusion with the cell membrane, releasing insulin into the bloodstream [6,7].”
BackgroundType 2 diabetes genes – Present status and data from Norwegian studies
Hertel, J. K., Johansson, S., Midthjell, K., Nygard, O. K., Njølstad, P. R., & Molven, A. (2013) · Norsk Epidemiologi · doi:10.5324/nje.v23i1.1597 · Cited by 14
“Notably, rare mutations in all four genes cause monogenic forms of diabetes (19-22), and two are targets of anti-diabetic therapies.”
BackgroundSelf-citationBeyond the beta cell in diabetes
Hattersley, A. T. (2006) · Nature Genetics · doi:10.1038/ng0106-12 · Cited by 9
Self-citationKawajiri, M., Okano, Y., Kuno, M., Tokuhara, D., Hase, Y., Inada, H., Tashiro, F., Miyazaki, J., & Yamano, T. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000198775.22719.46 · Cited by 9
“Mutations of KATP channels induce a variety of disturbances in glucose metabolism, such as persistent hyperinsulinemic hypoglycemia of infancy (PHHI) (21) and neonatal diabetes (22).”
BackgroundAydın, B. K., Bundak, R., Baş, F., Genç, H. M., Saka, N., Günöz, H., & Darendelıler, F. (2012) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.524 · Cited by 13
“respectively] of the ATP-sensitive potassium (KATP) channel and in the gene encoding insulin itself (3,4,5,6,7,8).”
BackgroundA V59M KCNJ11 gene mutation leading to intermediate DEND syndrome in a Chinese child
Sang, Y., Ni, G.-C., Gu, Y., & Liu, M. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.258 · Cited by 9
Zhang, R. S., Wright, J. D., Pless, S. A., Nuñez, J.-J., Kim, R. Y., Li, J. B. W., Yang, R. Y., Ahern, C. A., & Kurata, H. T. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.631960 · Cited by 9
“2 often diminish ATP sensitivity and underlie a monogenic form of neonatal diabetes with a dominant pattern of inheritance (14-16).”
BackgroundGurgel, L. C., & Moisés, R. S. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000200005 · Cited by 10
Ioacără, S., Flanagan, S. E., Fröhlich-Reiterer, E. E., Goland, R., & Fica, S. V. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12620 · Cited by 9
Lin, D.-C., Huang, C., Ting, W., Lo, F., Lin, C., Yang, H., Chang, T., Lin, C., Tzeng, Y.-W., Yang, W.-S., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.11.013 · Cited by 10
Ion Channels as Therapeutic Targets for Type 1 Diabetes Mellitus
Selvaraj, C., Selvaraj, G., Kaliamurthi, S., Cho, W. C. S., Wei, D., & Singh, S. K. (2019) · Current Drug Targets · doi:10.2174/1389450119666190920152249 · Cited by 9
Genetic effects, gene-lifestyle interactions, and type 2 diabetes
Qi, L. (2007) · Open Medicine · doi:10.2478/s11536-007-0051-1 · Cited by 10
Ligand-dependent Linkage of the ATP Site to Inhibition Gate Closure in the KATP Channel
Li, L., Geng, X., Yonkunas, M. J., Su, A.-J. A., Densmore, E., Tang, P. S., & Drain, P. F. (2005) · The Journal of General Physiology · doi:10.1085/jgp.200509289 · Cited by 9
Neonatal Diabetes Mellitus: Insights for More Common Forms of Diabetes
Polak, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1710 · Cited by 9
Letter re: Id1 Gene Expression in Hyperplastic and Neoplastic Thyroid Tissues
Rao, A. S., Goretzki, P. E., Köhrle, J., & Brabant, G. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0952 · Cited by 9
Mct11 deficiency alters hepatic glucose metabolism and energy homeostasisPreprint
Ainbinder, A., Zhao, L., Glover, P., Gelinas-Roa, K., Rusu, V., Harney, A. M., Hoch, E., Deik, A., Pierce, K. A., Bullock, K. H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.08.459307 · Cited by 9
“effective treatment approaches, and highlighting new target genes and pathways for drug development (Aquilante, 2010; Gloyn et al., 2004; Inzucchi, 2002; Pearson et al., 2003; Plenge et al., 2013; Shepherd et al., 2009).”
BackgroundInsulin regulates human pancreatic endocrine cell differentiation in vitro
Cota, P., Çalışkan, Ö. Ş., Bastidas-Ponce, A., Jing, C., Jaki, J., Saber, L., Czarnecki, O., Taskin, D., Blöchinger, A. K., Kurth, T., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101853 · Cited by 8
Nakhe, A. Y., Dadi, P. K., Kim, J., Dickerson, M. T., Behera, S., Dobson, J. R., Shrestha, S., Cartailler, J., Sampson, L. L., Magnuson, M. A., et al. (2024) · eLife · doi:10.7554/elife.89967 · Cited by 9
“K ATP R201H) results in complete inhibition of glucose-stimulated insulin secretion ( Gloyn et al., 2004 ).”
BackgroundHassan, S. S., Musa, S. A., Franco, E. D., Frew, R. D., Babiker, O., Mohamadsalih, G., Ibrahim, A. A., Samra, S. A., & Abdullah, M. A. (2024) · Pediatric Diabetes · doi:10.1155/2024/2032425 · Cited by 8
“2 and SUR1 subunits of the beta cell ATP-sensitive potassium (KATP) channel [7].”
RD Lawrence Lecture 2013 Stratified approaches to the management of diabetes
Pearson, E. R. (2013) · Diabetic Medicine · doi:10.1111/dme.12391 · Cited by 10
Self-citationTransient neonatal diabetes mellitus caused by ade novoABCC8gene mutation
Kong, J. H., & Kim, J. B. (2011) · Korean Journal of Pediatrics · doi:10.3345/kjp.2011.54.4.179 · Cited by 8
Cabezas, Ó. R., & Argente, J. (2012) · Anales de Pediatría · doi:10.1016/j.anpedi.2012.06.013 · Cited by 28
Iafusco, D., Zanfardino, A., Bonfanti, R., Rabbone, I., Tinto, N., IAFUSCO, F., Meola, S., Gicchino, M. F., Özen, G., Casaburo, F., et al. (2020) · Minerva Pediatrics · doi:10.23736/s0026-4946.20.05838-7 · Cited by 9
Costa‐Riquetto, A. D., de Santana, L. S., Franco, P. C., Junior, A. C. S., Martio, A. E., Lisboa, H. R. K., Kohara, S. K., & Teles, M. G. (2022) · Clinical Genetics · doi:10.1111/cge.14279 · Cited by 9
Pharmacogenetics of insulin secretagogue antidiabetics
Winkler, G., & Gerő, L. (2011) · Orvosi Hetilap · doi:10.1556/oh.2011.29175 · Cited by 8
Genetics of type 2 diabetes. On overview
Groop, L., & Lyssenko, V. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)73515-6 · Cited by 9
“In addition, an activating mutation in the gene causes a severe form of neonatal diabetes 7 .”
Neonatal Diabetes Mellitus: The Impact of Molecular Diagnosis
Pun, P., Clark, R., Wan, K., Peverini, R. L., & Merritt, T. A. (2010) · NeoReviews · doi:10.1542/neo.11-6-e306 · Cited by 8
Gach, A., Wyka, K., Pietrzak, I., Wegner, O., Malecki, M. T., & Mlynarski, W. M. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.07.011 · Cited by 8
Fanciullo, L., Iovane, B., Gkliati, D., Monti, G., Sponzilli, I., Cangelosi, A. M., Matrorilli, C., Chiari, G., Barbetti, F., Dall’Aglio, E., et al. (2012) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 8
Topić, E. (2013) · Journal of Medical Biochemistry · doi:10.2478/jomb-2013-0045 · Cited by 12
“In humans, KCNJ11 mutations underlie familial persistent hyperinsulinemic hypoglycemia of infancy (38, 39) and permanent neonatal diabetes (40), and are associated with common forms of T2D (41–48).”
BackgroundMonogenic forms of diabetes mellitus: an update
Vaxillaire, M., & Froguel, P. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)73513-2 · Cited by 11
“Heterogeneity in the symptoms associated with the K ATP channel mutations has been reported, notably neuromotor and neuropsychological abnormalities with distinctive degrees of severity may be present 4,5,7,9 .”
Yan, Z., Shyr, Z. A., Fortunato, M., Welscher, A., Alisio, M., Martino, M. R., Finck, B. N., Conway, H., & Remedi, M. S. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13423 · Cited by 8
Watson, M. R., Ward, C. T., Prabhakar, A., Fiza, B., & Moll, V. (2019) · Case Reports in Critical Care · doi:10.1155/2019/3560608 · Cited by 10
“Adenosine triphosphate-sensitive potassium (KATP) channels located in pancreatic β-cells play a key role in sensing plasma glucose levels and triggering the release of insulin to maintain euglycemia [21, 22].”
BackgroundHoutman, M. J. C., Friesacher, T., Chen, X., Zangerl‐Plessl, E., van der Heyden, M. A. G., & Stary‐Weinzinger, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.814066 · Cited by 8
An online monogenic diabetes discussion group: supporting families and fueling new research
Perrone, M. E., Carmody, D., Philipson, L. H., & Greeley, S. A. W. (2015) · Translational research · doi:10.1016/j.trsl.2015.06.013 · Cited by 8
Genetic framework of type 2 diabetes mellitus
Бондарь, И. А., & Шабельникова, О. Ю. (2013) · Diabetes Mellitus · doi:10.14341/dm2013411-16 · Cited by 17
Martins, L. C., Lourenço, R., Maia, A. L., Maciel, P. E. D. O., Monteiro, M. I., Pacheco, L., Anselmo, J., César, R., & Gomes, M. F. (2015) · Clinical Case Reports · doi:10.1002/ccr3.328 · Cited by 7
“The expression of KCNJ11 in the central nervous system and skeletal muscle explain the neurological features associated with syndromic forms of PNDM, such as developmental delay, muscle weakness, and epilepsy [16, 17].”
BackgroundThe impact of site-specific DNA methylation in KCNJ11 promoter on type 2 diabetes
Zhu, M., Huang, Q., Li, H., Zhao, Y., Guo, H., Wang, T., Liu, X., Huang, Y. L., Hu, J., Fang, C., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39934 · Cited by 10
Ioannou, Y. S., Ellard, S., Hattersley, A. T., & Skordis, N. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00743.x · Cited by 8
“2 (8) and sulfonylurea-receptor subunits (SUR1) (9,10) result in neonatal diabetes most frequently, PNDM.”
BackgroundSelf-citationGenome-Wide Association Studies of Type 2 Diabetes
SLADEK, R. M., & Prokopenko, I. (2016) · Springer eBooks · doi:10.1007/978-3-319-01574-3_2 · Cited by 7
“…for its treatment: while this is best demonstrated by the use of sulfonylureas to treat neonatal diabetes associated with inactivating mutations of the Sur1 protein (Gloyn et al. 2004), the same family of drugs have also provided a mainstay for treating adults with polygenic T2D for many years.”
BackgroundPollin, T. I., & Taylor, S. I. (2020) · Journal of Clinical Investigation · doi:10.1172/jci142364 · Cited by 7
Reevaluation of a case of type 1 diabetes mellitus diagnosed before 6 months of age
Jones, A. G., & Hattersley, A. T. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.42 · Cited by 7
Self-citationCan geneticists help clinicians to understand and treat non-autoimmune diabetes?
Malecki, M. T., Mlynarski, W. M., & SKUPIEN, J. K. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.020 · Cited by 7
Remedi, M. S., & Nichols, C. G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802002-9.00008-x · Cited by 9
Peña-Almazan, S. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.12.010 · Cited by 7
Methods for Characterizing Disease-Associated ATP-Sensitive Potassium Channel Mutations
Kandasamy, B., & Shyng, S. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7362-0_8 · Cited by 7
Identification of insulin gene variants in patients with neonatal diabetes in the Chinese population
Fu, J., Wang, T., Li, M., & Xiao, X. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13156 · Cited by 8
Devaraja, J., Elder, C. J., & Scott, A. R. (2020) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-19-0125 · Cited by 7
Electrophysiology of Islet Cells
Drews, G., Krippeit‐Drews, P., & Düfer, M. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_5 · Cited by 9
Bremer, A. A., Ranadive, S. A., & Lustig, R. H. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00316.x · Cited by 7
Scharfmann, R., & Hamilton-Shield, J. P. (2007) · Endocrine development · doi:10.1159/isbn.978-3-8055-8386-2 · Cited by 7
Nurkolis, F., Syahputra, R. A., Nugrahanto, A. P., Taslim, N. A., Mustika, A., Tjandrawinata, R. R., Harbuwono, D. S., & Soegondo, S. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01762-0 · Cited by 7
Silvestri, F. (2016) · Pediatrics & Therapeutics · doi:10.4172/2161-0665.1000274 · Cited by 6
“A subgroup of mutations cause severe clinical profile characterized by delayed development of motor, intellectual and social skills, muscle weakness, epilepsy, facial dimorphisms and Neonatal Diabetes (DEND syndrome) [13-15].”
BackgroundA homozygous TARS2 variant is a novel cause of syndromic neonatal diabetes
Donis, R., Patel, K., Wakeling, M. N., Johnson, M. B., Amoli, M. M., Yıldız, M., Akçay, T., Irani, A. J., Yong, J., Yaghootkar, H., et al. (2024) · Diabetic Medicine · doi:10.1111/dme.15471 · Cited by 8
“…gain- of-function KCNJ11 and ABCC8 variants which cause developmental delay, epilepsy, and diabetes through disruption of insulin secretion and neurotransmitter release 2,3 ; and loss- of-function PTF1A variants which cause pancreatic and cerebellar agenesis through defective organ development.”
Self-citationGenetic Polymorphisms and Ischemic Heart Disease
Fedele, F., Pucci, M., & Severino, P. (2017) · InTech eBooks · doi:10.5772/intechopen.69621 · Cited by 6
Hajji, S. A., Aljenaee, K., Garrahy, A., & Byrne, M. M. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-239973 · Cited by 6
Dorothy Hodgkin Lecture 2021: Drugs, genes and diabetes
Pearson, E. R. (2021) · Diabetic Medicine · doi:10.1111/dme.14726 · Cited by 6
Self-citationGenetic Determinants Predicting Efficacy of Glucose-Lowering Drugs?
Nauck, M. A., & Vardarli, I. (2010) · Diabetes Care · doi:10.2337/dc10-1263 · Cited by 6
“In the long run, multiple genetic traits, such as polymorphisms related to TCF7L2 (21–24), FOXO1 (25), and WFS1 (26); potassium channels associated with sulfonylurea receptors (5); and many more aspects of -cell mass and function, including parameters related to insulin resistance, may as a whole help predict the indi…”
BackgroundAssociation of the Kir6.2 E23K Variant with Reduced Acute Insulin Response in African-Americans
Palmer, N. D., Langefeld, C. D., Bryer‐Ash, M., Rotter, J. I., Taylor, K. D., & Bowden, D. W. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0543 · Cited by 6
Genetics of type 2 diabetes in Arabs: What we know to date
Meyer, B. F., Alsmadi, O. A., Wakil, S. M., & Al-Rubeaan, K. A. (2009) · International Journal of Diabetes Mellitus · doi:10.1016/j.ijdm.2009.03.003 · Cited by 7
Grant, R. W., & Wexler, D. J. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.5 · Cited by 8
Historical Perspective on the Genetic Forms of Congenital Hyperinsulinism
Stanley, C. A., & Matschinsky, F. M. (2012) · Frontiers in diabetes · doi:10.1159/000334444 · Cited by 6
Failure of TRIGR Study Opens Door to Alternative Explanation of T1DM Etiopathology
Dow, C. T. (2018) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000e112 · Cited by 6
Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene
Döneray, H., Houghton, J., Tekgündüz, K. Ş., BALKIR, F., & Caner, İ. (2013) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0068 · Cited by 6
“This patient had no neurological finding, although she was determined to have a mutation in the same residue of KCNJ11 as in the previously reported cases (3, 8).”
BackgroundResultInfluentialHong, H., Kamerman‐Kretzmer, R., Kato, R. M., Rosser, T. L., Hirtum-Das, M. V., & Ward, S. L. D. (2018) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7288 · Cited by 6
Structure based analysis of KATP channel with a DEND syndrome mutation in murine skeletal muscle
Horita, S., Ono, T., González-Resines, S., Ono, Y., Yamachi, M., Zhao, S., Domene, C., Maejima, Y., & Shimomura, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-86121-5 · Cited by 6
Sood, S., Landreth, H., Bustinza, J., Chalmers, L. J., & Thukaram, R. (2017) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/2324709617698718 · Cited by 6
Yoon, J. S., Park, K. J., Sohn, Y. B., Lee, H. S., & Hwang, J. S. (2018) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2018.23.3.154 · Cited by 6
Emerging technologies in pediatrics: the paradigm of neonatal diabetes mellitus
Nicolaides, N. C., Kanaka‐Gantenbein, C., Papadopoulou‐Marketou, N., Sertedaki, A., Chrousos, G. P., & Papassotiriou, I. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1752141 · Cited by 8
“and ABCC8, which are responsible for 31% and 10% of cases, respectively [5,25,26].”
BackgroundVogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_12 · Cited by 6
Genetic Testing in Diabetes Mellitus
Philipson, L. H., Murphy, R., Ellard, S., Hattersley, A. T., Støy, J., Greeley, S. A. W., Bell, G. I., & Polonsky, K. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374430-2.00002-x · Cited by 6
Self-citationJones, A. G., & Hattersley, A. T. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch15 · Cited by 10
Self-citationCommentary: Sub-types of diabetes--what's new and what's not
Wild, S. H., & Byrne, C. D. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt201 · Cited by 6
Cooper, E. C., & Pan, Z. (2007) · Neurology · doi:10.1212/01.wnl.0000275538.19348.bd · Cited by 6
“choose glibenclamide, and why did an oral agent work after insulin had failed? The authors recognized that their patient had delay, epilepsy, and neonatal diabetes (DEND) syndrome, which is caused by mutations in a potassium ion (K ) channel, KATP.(3) Understanding the disorder and therapeutic response requires a few…”
BackgroundInfluentialOxidant-induced disruption of vascular K + channel function: implications for diabetic vasculopathy
Nwokocha, C. R., Palacios, J. C., Ojukwu, V. E., Nna, V. U., Owu, D. U., Nwokocha, M., McGrowder, D. A., & Orie, N. N. (2022) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2022.2090578 · Cited by 5
“Gloyn et al. (2004) reported that mutation in KCNJ11 gene encoding the Kir6.”
BackgroundGenome-edited zebrafish model of ABCC8 loss-of-function disease
Iklé, J. M., Tryon, R. C., Singareddy, S. S., York, N., Remedi, M. S., & Nichols, C. G. (2022) · Islets · doi:10.1080/19382014.2022.2149206 · Cited by 5
Gökşen, D., Darcan, Ş., Çöker, M., Aksu, G., Yıldız, B., Kara, S., & Kültürsay, N. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2006.00201.x · Cited by 5
“(24) had shown neurologic abnormalities in three patients with PNDM with activating muta-”
BackgroundDiabètes sucrés du très jeune enfant
Busiah, K., Vaivre‐Douret, L., Yachi, C., Cavé, H., & Polak, M. (2013) · Archives de Pédiatrie · doi:10.1016/s0929-693x(13)71425-8 · Cited by 7
Association of KCNJ11 with impaired glucose regulation in essential hypertension
Wang, Y., Zhou, X., Zhang, Y., Gao, P., & Zhu, D. (2011) · Genetics and Molecular Research · doi:10.4238/vol10-2gmr1127 · Cited by 5
“…in KCNJ11 cause decreased function of the KATP channels, leading to persistent hyperinsulinemic hypoglycemia of infancy in humans (Lin et al., 2008); on the contrary, activating mutations in this gene lead to permanent neonatal diabetes due to overactive KATP channels (Gloyn et al., 2004).”
BackgroundModeling Type 2 Diabetes GWAS Candidate Gene Function in hESCs
Rutter, G. A. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.08.010 · Cited by 5
“2) subunit of the ATP-sensitive K + channel complex (KATP), and has a coding variant (E23K) linked to monogenic forms of type 2 diabetes (permanent neonatal diabetes) (Gloyn et al., 2004), and is also located close to a diabetes risk SNP (Zeggini et al., 2007).”
BackgroundAgasid, M. T., Wang, X., Huang, Y., Janczak, C. M., Bränström, R., Saavedra, S. S., & Aspinwall, C. A. (2018) · Protein Expression and Purification · doi:10.1016/j.pep.2018.01.015 · Cited by 6
Zhu, Y., Tonne, J. M., Liu, Q., Schreiber, C. A., Zhou, Z., Rakshit, K., Matveyenko, A. V., Terzic, A., Wigle, D. A., Kudva, Y. C., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.07.006 · Cited by 6
“, 2006), KCNJ11 (Gloyn et al., 2004), CACNA1D (Reinbothe et al.”
BackgroundHypoglycaemia: Still the main drawback of insulin 100 years on: “From man to mouse”
Merchant, H. J., & McNeilly, A. D. (2021) · Diabetic Medicine · doi:10.1111/dme.14721 · Cited by 5
The insulin centennial—100 years of milestones in biochemistry
Attie, A., Tang, Q.-Q., & Bornfeldt, K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101278 · Cited by 6
“Loss-of-function mutations in SUR1 or less commonly, KCNJ11, lead to hyperinsulinism (19), whereas mutations in KCNJ11 that decrease ATP inhibition of KATP cause neonatal permanent neonatal diabetes (20).”
Background
Metadata
- Authors
- Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., Edghill, E. L., Frayling, T. M., Temple, I. K., Mackay, D., Shield, J. P. H., Sumnik, Z., van Rhijn, A., Wales, J. K. H., Clark, P., Gorman, S., Aisenberg, J., Ellard, S., Njølstad, P. R., Ashcroft, F. M., & Hattersley, A. T.
- Affiliations
- University of Exeter (GB)
- University of Oxford (GB)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Children's Hospital at Westmead (AU)
- University of Bergen (NO)
- National Health Service (GB)
- Salisbury District Hospital (GB)
- Sheffield Children's Hospital (GB)
- St. Luke's Hospital (GB)
- Hackensack University Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-04-29
- Volume
- 350
- Issue
- 18
- Pages
- 1838-1849
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012515461
- Cited by
- 1,137
- References
- 38
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 31 · 2023: 44 · 2022: 37 · 2021: 49 · 2020: 33 · 2019: 50 · 2018: 57 · 2017: 51 · 2016: 55 · 2015: 49 · 2014: 60 · 2013: 55 · 2012: 45
- FWCI
- 70.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- permanent neonatal diabetes, Kir6.2, KCNJ11, ATP-sensitive potassium channels, activating mutations, missense mutations, SUR1, tolbutamide, glucose-stimulated insulin secretion, developmental delay, muscle weakness, epilepsy, genetic diagnosis
- MeSH terms
- Developmental Disabilities, Diabetes Mellitus, DNA Mutational Analysis, Epilepsy, Face, Female, Heterozygote, Humans, Infant, Newborn, Islets of Langerhans, Male, Mutation, Pedigree, Sequence Analysis, DNA, Potassium Channels, Inwardly Rectifying
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.